KK
AXSM icon

KLP Kapitalforvaltning’s Axsome Therapeutics AXSM Stock Holding History

KLP Kapitalforvaltning’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55M Buy
9,200
+200
+2% +$34.5K 0.01% 820
2025
Q4 		$1.64M Hold
9,000
– – 0.01% 799
2025
Q3 		$1.09M Sell
9,000
-2,200
-20% -$248K ﹤0.01% 979
2025
Q2 		$1.17M Buy
11,200
+3,000
+37% +$318K 0.01% 895
2025
Q1 		$956K Sell
8,200
-600
-7% -$68.4K ﹤0.01% 958
2024
Q4 		$745K Buy
+8,800
New +$809K ﹤0.01% 1131

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KLP Kapitalforvaltning's AXSM Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its Axsome Therapeutics (AXSM) stake by 2.2% in Q1 2026, buying an estimated $34.5K and bringing the position to 9,200 shares worth $1.55M. The position accounts for 0.01% of the portfolio, ranked #820.

KLP Kapitalforvaltning first reported a position in AXSM in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.64M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • KLP Kapitalforvaltning held 9,200 shares of Axsome Therapeutics worth $1.55M as of Q1 2026.
  • KLP Kapitalforvaltning bought 200 Axsome Therapeutics shares in Q1 2026, an estimated $34.5K.
  • Axsome Therapeutics made up 0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #820 holding.
  • KLP Kapitalforvaltning first reported a position in Axsome Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's Axsome Therapeutics position peaked at $1.64M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.